Alexium International Group Past Earnings Performance
Past criteria checks 0/6
Alexium International Group has been growing earnings at an average annual rate of 17.6%, while the Chemicals industry saw earnings growing at 11.8% annually. Revenues have been declining at an average rate of 10% per year.
Key information
17.6%
Earnings growth rate
31.1%
EPS growth rate
Chemicals Industry Growth | 12.9% |
Revenue growth rate | -10.0% |
Return on equity | n/a |
Net Margin | -59.8% |
Last Earnings Update | 31 Dec 2022 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Alexium International Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 22 | 6 | -4 | 4 | 1 |
30 Sep 22 | 7 | -4 | 4 | 1 |
30 Jun 22 | 8 | -3 | 4 | 1 |
31 Mar 22 | 9 | -2 | 4 | 1 |
31 Dec 21 | 9 | -2 | 4 | 1 |
30 Sep 21 | 8 | -2 | 4 | 1 |
30 Jun 21 | 7 | -1 | 4 | 1 |
31 Mar 21 | 7 | -2 | 4 | 1 |
31 Dec 20 | 7 | -4 | 4 | 1 |
30 Sep 20 | 6 | -5 | 4 | 0 |
30 Jun 20 | 6 | -6 | 4 | 0 |
31 Mar 20 | 6 | -7 | 5 | 0 |
31 Dec 19 | 7 | -8 | 5 | 0 |
30 Sep 19 | 6 | -8 | 5 | 0 |
30 Jun 19 | 5 | -7 | 5 | 0 |
31 Mar 19 | 6 | -6 | 5 | 0 |
31 Dec 18 | 7 | -6 | 5 | 0 |
30 Sep 18 | 9 | -5 | 5 | 1 |
30 Jun 18 | 12 | -4 | 5 | 1 |
31 Mar 18 | 14 | -5 | 6 | 1 |
31 Dec 17 | 16 | -6 | 6 | 1 |
30 Sep 17 | 17 | -8 | 6 | 1 |
30 Jun 17 | 18 | -9 | 6 | 1 |
31 Mar 17 | 14 | -9 | 6 | 2 |
31 Dec 16 | 9 | -9 | 5 | 2 |
30 Sep 16 | 6 | -11 | 7 | 2 |
30 Jun 16 | 2 | -12 | 9 | 1 |
Quality Earnings: AXII.F is currently unprofitable.
Growing Profit Margin: AXII.F is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: AXII.F is unprofitable, but has reduced losses over the past 5 years at a rate of 17.6% per year.
Accelerating Growth: Unable to compare AXII.F's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: AXII.F is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-7%).
Return on Equity
High ROE: AXII.F's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.